bioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Drop in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 104,300 shares, a drop of 10.2% from the January 15th total of 116,100 shares. Based on an average daily volume of 4,900 shares, the short-interest ratio is presently 21.3 days.

bioMérieux Price Performance

Shares of BMXMF stock opened at $116.75 on Friday. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. bioMérieux has a 12-month low of $93.50 and a 12-month high of $123.44. The stock’s 50-day moving average price is $111.33 and its 200-day moving average price is $111.36.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.